Table 2.
Minimal change disease |
IFN-α and -β |
Pamidronate |
Lithium |
Nonsteroidal anti-inflammatory drugs |
Cyclooxygenase-2 inhibitors |
FSGS |
IFN-α and -γ |
Pamidronate |
Lithium |
Sirolimus |
Anabolic steroids |
Collapsing FSGS |
IFN-α, -β, and -γ |
Pamidronate (rarely zoledronate or alendronate) |
Anabolic steroids |